Options Brief: Oncothyreon Inc.

Shares of Oncothyreon Inc.

are higher on the session by 8.11%, trading at $9.26. Overall call volume is now running at 2.93x the daily average, with 71% of all calls traded being purchases on the offer. 5,161 contracts have traded on the session so far. Oncothyreon Inc. is a clinical-stage biopharmaceutical company. The company focuses primarily on the development of therapeutic products for the treatment of cancer.